多替阿巴拉米片国内买的到吗?
(Dolutegravir tablets) is the only three-in-one compound drug containing dolutegravir (DTG). It has the characteristics of high efficacy, good tolerability, high resistance barrier, and few drug interactions. One tablet per day can significantly reduce the medication burden of AIDS patients, thereby improving patients' medication compliance and significantly improving their quality of life. Thirty years ago, AIDS was a fatal disease, but now, through the joint efforts of doctors and scientists, significant progress has been made in AIDS treatment, and AIDS is now becoming a chronic disease that can be completely controlled.
Suimeikai (dolute abalamib tablets) has been approved in more than 70 countries, and has been recommended by many authoritative academic institutions in Europe and the United States as the first-line treatment of choice for newly treated AIDS patients.
Is it possible to buy Abalami Tablets in China? After Suimeikai (Domitabalamid Tablets) is launched in China, patients can buy it in some large domestic hospitals with the prescriptions issued by doctors, without having to go abroad, which is more convenient. However, as an original drug, the price of Suimeike (Dolutea Paramid Tablets) is relatively high, which puts many patients under great long-term financial pressure.
Medical Companion Travel has learned that Suimeike (Domitabalamid Tablets) has also been launched in India. It is produced by Emcure Company. The effect is the same as that of the original domestic drug. There are 30 tablets per box and the price is about $1,000, which is much lower than the domestic price. It is a good choice for patients. If it is inconvenient for patients to go abroad, they can also use direct mail through Medical Companion Travel to send medicines directly from Indian pharmacies to patients, and patients do not have to worry about buying counterfeit medicines.
For more information, please contact Medical Companion Travel for details and we will be happy to answer your questions.
Recommended related hot articles: /newsDetail/77157.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)